Tags

Type your tag names separated by a space and hit enter

Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.
Virology. 2002 Jul 20; 299(1):109-21.V

Abstract

Epstein-Barr virus (EBV) encodes multiple latency programs: a growth-transforming program (type III) latency program and restricted-latency (types I and II) programs. During type III latency, EBV expresses six nuclear antigens, all of which are encoded by a single complex transcriptional unit driven by two linked promoters, Cp and Wp, while restricted viral latency is characterized by the expression of a single nuclear antigen, EBNA1, whose expression is driven from a distinct transcription unit under the control of the Qp promoter. EBV infection of the 293 epithelial cell line frequently leads to the establishment of a type I/II latent infection. Here we report that during the initial stages of virus infection of the 293 cell line, both Cp and Wp are active. However, analysis of four established, low-passage EBV-infected 293 cell lines revealed that three of these exhibited Qp-driven transcription of the EBNA 1 gene and little or no detectable Cp and Wp activity, while the fourth cell line exhibited Cp activity. Notably, all four cell lines contained the necessary transcription factors to drive transcription initiation from Cp and Wp when transiently transfected with unmethylated reporter constructs. Furthermore, in the cell lines exhibiting restricted EBV latency the viral genomes were extensively methylated around Cp and Wp, but not Qp. In contrast, in the cell line exhibiting Cp activity the viral genomes were hypomethylated around Cp, Wp, and Qp. Taken together, these results provide evidence that the establishment of a restricted latent infection in the 293 epithelial cell line is not due to a failure to initiate the growth-transforming (type III) latency program, but rather may arise from a selection against the type III latency program. Furthermore, these results are consistent with the hypothesis that methylation of Cp and Wp is required for entry into the type I or II latency programs.

Authors+Show Affiliations

Immunology Graduate Program, Washington University School of Medicine, St. Louis, Missouri 63110, USA.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

12167346

Citation

Paulson, Emily J., et al. "Methylation of the EBV Genome and Establishment of Restricted Latency in Low-passage EBV-infected 293 Epithelial Cells." Virology, vol. 299, no. 1, 2002, pp. 109-21.
Paulson EJ, Fingeroth JD, Yates JL, et al. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Virology. 2002;299(1):109-21.
Paulson, E. J., Fingeroth, J. D., Yates, J. L., & Speck, S. H. (2002). Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Virology, 299(1), 109-21.
Paulson EJ, et al. Methylation of the EBV Genome and Establishment of Restricted Latency in Low-passage EBV-infected 293 Epithelial Cells. Virology. 2002 Jul 20;299(1):109-21. PubMed PMID: 12167346.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. AU - Paulson,Emily J, AU - Fingeroth,Joyce D, AU - Yates,John L, AU - Speck,Samuel H, PY - 2002/8/9/pubmed PY - 2002/11/26/medline PY - 2002/8/9/entrez SP - 109 EP - 21 JF - Virology JO - Virology VL - 299 IS - 1 N2 - Epstein-Barr virus (EBV) encodes multiple latency programs: a growth-transforming program (type III) latency program and restricted-latency (types I and II) programs. During type III latency, EBV expresses six nuclear antigens, all of which are encoded by a single complex transcriptional unit driven by two linked promoters, Cp and Wp, while restricted viral latency is characterized by the expression of a single nuclear antigen, EBNA1, whose expression is driven from a distinct transcription unit under the control of the Qp promoter. EBV infection of the 293 epithelial cell line frequently leads to the establishment of a type I/II latent infection. Here we report that during the initial stages of virus infection of the 293 cell line, both Cp and Wp are active. However, analysis of four established, low-passage EBV-infected 293 cell lines revealed that three of these exhibited Qp-driven transcription of the EBNA 1 gene and little or no detectable Cp and Wp activity, while the fourth cell line exhibited Cp activity. Notably, all four cell lines contained the necessary transcription factors to drive transcription initiation from Cp and Wp when transiently transfected with unmethylated reporter constructs. Furthermore, in the cell lines exhibiting restricted EBV latency the viral genomes were extensively methylated around Cp and Wp, but not Qp. In contrast, in the cell line exhibiting Cp activity the viral genomes were hypomethylated around Cp, Wp, and Qp. Taken together, these results provide evidence that the establishment of a restricted latent infection in the 293 epithelial cell line is not due to a failure to initiate the growth-transforming (type III) latency program, but rather may arise from a selection against the type III latency program. Furthermore, these results are consistent with the hypothesis that methylation of Cp and Wp is required for entry into the type I or II latency programs. SN - 0042-6822 UR - https://www.unboundmedicine.com/medline/citation/12167346/Methylation_of_the_EBV_genome_and_establishment_of_restricted_latency_in_low_passage_EBV_infected_293_epithelial_cells_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0042682202914571 DB - PRIME DP - Unbound Medicine ER -